Meta-analysis of Pregnancy Events in Biomedical HIV Prevention Trials in Sub-Saharan Africa: Implications for Gender Transformative Trials

被引:0
|
作者
Lorenzetti, Lara [1 ]
Dinh, Nhi [1 ]
Whitcomb, Cason [1 ]
Martinez, Andres [1 ]
Chatani, Manju [2 ]
Lievense, Breanne [2 ]
Nhamo, Definate [3 ]
Slack, Catherine [4 ]
Eley, Natalie [1 ]
Macqueen, Kathleen [1 ]
机构
[1] FHI 360, Behav Epidemiol & Clin Sci Div, Durham, NC 27701 USA
[2] AVAC, New York, NY USA
[3] Pangaea Zimbabwe, Harare, Zimbabwe
[4] Univ KwaZulu Natal, Sch Law, Pietermaritzburg, South Africa
关键词
Meta-analysis; Biomedical HIV prevention trials; Pregnancy; Eligibility criteria; Gender transformative; DAPIVIRINE VAGINAL RING; RANDOMIZED CONTROLLED SAFETY; SEXUALLY ACTIVE WOMEN; PREEXPOSURE PROPHYLAXIS; CONTRACEPTIVE USE; DOUBLE-BLIND; MICROBICIDE GEL; SOUTH-AFRICA; MONOCLONAL-ANTIBODY; VACCINE EFFICACY;
D O I
10.1007/s10461-024-04459-z
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Historically, pregnant and lactating populations (PLP) have been excluded or disenrolled from biomedical HIV prevention trials, despite being more likely to acquire HIV during pregnancy and the post-partum period. We conducted a meta-analysis of pregnancy events in biomedical HIV prevention trials in sub-Saharan Africa to support trialists moving toward more inclusive clinical and implementation studies. We searched peer-reviewed literature reporting pregnancy events and contraceptive requirements in HIV prevention trials between 2001 and 2022. We hypothesized four variables to explain variation: contraceptive requirements, study start year, study product, and sub-region. We fit a meta-analytic model to estimate individual effect sizes and sampling variances, then conducted sub-group analyses to assess moderating effects. We identified 38 references for inclusion, across which the proportion of pregnancy events was 8% (95% confidence interval [CI]: 6-10%) with high heterogeneity (I-2 = 99%). Studies not requiring contraceptives (21%, 95%CI: 7-48%) reported a significantly higher proportion of pregnancy events than studies requiring two methods (5%, 95%CI: 2-10%). Studies launched between 2001 and 2007 (11%, 95%CI: 8-16%), microbicide gel trials (12%, 95%CI: 8-18%), and studies conducted in Western Africa (28%, 95%CI: 13-51%) reported higher proportions of pregnancy events than reference groups. Together, these variables have a moderating effect on pregnancy events (p < 0.0001), explaining 63% of heterogeneity in trials. Results describe how, over time, more stringent contraceptive requirements reduced pregnancy events, which ensured necessary statistical power but limited reproductive choice by participants. With the move toward continuing PLP on experimental products, trialists can utilize estimated pregnancy events reported here to inform strategies that accommodate participants' changing fertility preferences.
引用
收藏
页码:3850 / 3872
页数:23
相关论文
共 50 条
  • [31] Healthcare providers' understanding of HIV serodiscordance in South Africa and Uganda: implications for HIV prevention in sub-Saharan Africa
    Greener, Ross
    Milford, Cecilia
    Bajunirwe, Francis
    Mosery, Faith N.
    Ng, Claudia K.
    Rifkin, Rachel
    Kastner, Jasmine
    Pillay, Lavanya
    Kaida, Angela
    Bangsberg, David R.
    Smit, Jennifer A.
    Matthews, Lynn T.
    AJAR-AFRICAN JOURNAL OF AIDS RESEARCH, 2018, 17 (02): : 137 - 144
  • [32] UPTAKE OF COUPLES HIV TESTING AND COUNSELLING IN SUB-SAHARAN AFRICA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Hailemariam, Tewodros Getachew
    Nathan, Sally
    Seifu, Canaan
    Rawstorne, Patrick
    SEXUALLY TRANSMITTED INFECTIONS, 2019, 95 : A85 - A86
  • [33] Transactional sex and risk for HIV infection in sub-Saharan Africa: a systematic review and meta-analysis
    Wamoyi, Joyce
    Stobeanau, Kirsten
    Bobrova, Natalia
    Abramsky, Tanya
    Watts, Charlotte
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [34] HIV Prevalence Among Tuberculosis Patients in Sub-Saharan Africa: A Systematic Review and Meta-analysis
    Gelaw, Yalemzewod Assefa
    Williams, Gail
    Magalhaes, Ricardo J. Soares
    Gilks, Charles F.
    Assefa, Yibeltal
    AIDS AND BEHAVIOR, 2019, 23 (06) : 1561 - 1575
  • [35] An analysis of stroke risk factors by HIV serostatus in Uganda: Implications for stroke prevention in sub-Saharan Africa
    Mbonde, Amir A.
    Chang, Jonathan
    Musubire, Abdu
    Okello, Samson
    Kayanja, Adrian
    Acan, Moses
    Nkwanga, Jacob
    Katende, Andrew
    Chow, Felicia C.
    Saylor, Deanna
    O'Carroll, Cumara
    Siedner, Mark J.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2022, 31 (07):
  • [36] Declining HIV incidence in sub-Saharan Africa: a systematic review and meta-analysis of empiric data
    Joshi, Keya
    Lessler, Justin
    Olawore, Oluwasolape
    Loevinsohn, Gideon
    Bushey, Sophrena
    Tobian, Aaron A. R.
    Grabowski, M. Kate
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 (10)
  • [37] The effect of gender inequality on HIV incidence in Sub-Saharan Africa
    Sia, D.
    Tchouaket, E. Nguemeleu
    Hajizadeh, M.
    Karemere, H.
    Onadja, Y.
    Nandi, A.
    PUBLIC HEALTH, 2020, 182 : 56 - 63
  • [38] Maximizing the impact of HIV prevention technologies in sub-Saharan Africa
    Ward, Helen
    Garnett, Geoffrey P.
    Mayer, Kenneth H.
    Dallabetta, Gina A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22
  • [39] Modernizing Sexuality: US HIV Prevention in Sub-Saharan Africa
    Schatz, Enid
    JOURNAL OF MODERN AFRICAN STUDIES, 2018, 56 (01): : 183 - 184
  • [40] Modernizing Sexuality: US HIV Prevention in Sub-Saharan Africa
    Booth, Karen M.
    GENDER & SOCIETY, 2017, 31 (05) : 707 - 709